Product/Service
DIA/FDA Orphan Drug Designation Workshop
Source: DIA
In Collaboration with the National Organization for Rare Disorders (NORD) and Genetic Alliance FDA announced the launch of the Orphan Drug Designation Workshop series presenting an opportunity for academics, biotechnology companies and larger pharmaceutical firms to spend two days in creation of applications for orphan status designation.
Click Here To Download:
•Event Brochure: DIA/FDA Orphan Drug Designation Workshop
•Event Brochure: DIA/FDA Orphan Drug Designation Workshop
•Event Brochure: DIA/FDA Orphan Drug Designation Workshop
Date(s) And Time(s):
Nov 4 2010 8:00AM - Nov 5 2010 5:00PM
Location:
The National Conference Center
18980 Upper Belmont Place
Lansdowne, VA 20176
Interest Area(s):
Clinical Research, Project Management, Research & Development
Overview:
Registration is limited (maximum of 3 persons per organization) and is accepted on a first-come, first-served basis.
Registration closes October 27, 2010; on-site registration will not be available for this workshop.
Click here to view program. Special registration instructions are on page 3.
Click Here To Download:•Event Brochure: DIA/FDA Orphan Drug Designation Workshop
Need More Information? Just Ask.
Click the button below to directly contact the supplier. Use it to:
- Ask a question.
- Request more detailed information or literature.
- Discuss your current project/application.
- Request a quote.
- Locate a distributor in your area.
- Schedule a demo.
